Potential acute hepatic injury in 2 cats exposed to topical human diclofenac.

Read full text Summarise with VIRAT
Authors: Shino Yoshida, Tanarut Laudhittirut, Vanessa Cowan, Melissa D. Meachem, Kevin Cosford
Cited by: 0
References: 1

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

liquid chromatography-mass spectrometry detected diclofenac in both cats (30 μg/mL in Cat 1, 42 μg/mL in Cat 2). The toxic threshold of diclofenac in cats is currently unknown. Although direct evidence linking acute liver injury to diclofenac exposure was lacking in this case, the report does highlight the potential risk to pet cats whose owners use topical diclofenac. Key clinical message: Topical NSAID formulations such as diclofenac are commonly used by pet owners to treat human pain. The risk to pets, particularly smaller animals exposed to human skin upon which transdermal medication has been applied, remains unknown. Pet owners should be made aware of the potential risks these products pose to animals. Also, to the authors' knowledge, this is the first case report to describe "critical green inclusions" in a cat with severe liver disease.

Fields of Study & Subjects

Drug-Induced Hepatotoxicity and Protection Veterinary Pharmacology and Anesthesia Poisoning and overdose treatments

Publication details

Journal / source
PubMed
Volume
67
Issue
3
Pages
267–274
Publication date
1 March 2026
Language
EN